000503.SHE China Reform Health Management and Services Group Co Ltd
- Market cap
- CNY 6.37B
- P/E
- -
- P/B
- 5.92x
- ROE
- -17.7%
- Dividend yield
- 0.09%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 000503.SHE undervalued?
Graham numberThe Graham number of China Reform Health Management and Services Group Co Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
China Reform Health Management and Services Group Co Ltd fundamental analysis
No fundamental analysis for China Reform Health Management and Services Group Co Ltd yet.
China Reform Health Management and Services Group Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About China Reform Health Management and Services Group Co Ltd
China Reform Health Management and Services Group Co., Ltd. offers medical insurance management services in China. The company provides medical insurance fund management, medical quality and safety, drug and medical device supervision, and internet-based health protection services. It is also involved in the pharmaceutical and medical business. The company was formerly known as SeaRainbow Holding Corp. and changed its name to China Reform Health Management and Services Group…
Full company profileChina Reform Health Management and Services Group Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
China Reform Health Management and Services Group Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 217M | 99.0M | 95.5M | 130M | 207M | 253M | 311M | 330M | 357M | 350M | 221M |
| Gross Profit | 71.5M | 73.1M | -60.9M | -33.4M | 30.5M | 33.8M | 64.5M | 82.0M | 54.4M | 74.3M | -12.4M |
| Operating Income | 24.8M | 6.84M | -183M | 16.1M | -242M | -176M | -84.5M | -82.7M | -15.8M | -142M | -191M |
| EBITDA | -93.5M | -124M | -185M | -167M | -97.1M | -143M | -82.2M | -89.4M | -135M | -349M | -178M |
| Net Income | 28.0M | 16.7M | -188M | 17.4M | -243M | -176M | -84.3M | -79.8M | -10.4M | -404M | -190M |
| EPS | 0.03 | 0.02 | -0.21 | 0.02 | -0.27 | -0.20 | -0.09 | -0.09 | -0.01 | -0.41 | -0.19 |
| Balance Sheet | |||||||||||
| Total Assets | 1.49B | 1.45B | 1.28B | 1.31B | 1.30B | 1.19B | 1.10B | 1.95B | 2.06B | 1.80B | 1.56B |
| Total Liabilities | 79.1M | 55.6M | 62.7M | 77.7M | 333M | 405M | 392M | 530M | 656M | 792M | 480M |
| Shareholders' Equity | 1.42B | 1.41B | 1.21B | 1.22B | 961M | 786M | 711M | 1.42B | 1.41B | 1.01B | 1.08B |
| Cash & Short-term Investments | 1.04B | 707M | 740M | 810M | 939M | 757M | 589M | 1.38B | 1.31B | 559M | 276M |
| Total Debt | 830K | 65.4K | - | - | 50.1M | 49.7M | 55.1M | 191M | 262M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 22.9M | -242M | -23.2M | 66.0M | -93.0M | -105M | -160M | -102M | -82.5M | -81.7M | - |
| Capital Expenditure | 110M | 93.2M | 37.5M | 32.5M | 17.7M | 23.1M | 37.7M | 52.1M | 37.6M | 45.7M | 32.0M |
| Free Cash Flow | -86.7M | -335M | -60.7M | 33.5M | -111M | -128M | -198M | -154M | -120M | -127M | -289M |
| Ratios | |||||||||||
| ROE | 2.0% | 1.2% | -15.5% | 1.4% | -25.2% | -22.4% | -11.9% | -5.6% | -0.7% | -40.1% | -17.7% |
| ROA | 1.9% | 1.2% | -14.7% | 1.3% | -18.7% | -14.7% | -7.6% | -4.1% | -0.5% | -22.4% | -12.2% |
| Net Profit Margin | 12.9% | 16.8% | -196.6% | 13.4% | -117.0% | -69.6% | -27.1% | -24.2% | -2.9% | -115.3% | -86.1% |
| Debt to Equity | 0.00x | 0.00x | - | - | 0.05x | 0.06x | 0.08x | 0.13x | 0.19x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
China Reform Health Management and Services Group Co Ltd dividends
- Dividend yield
- 0.09%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- May 31, 2004
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 5.82M | 0.01 | - |
| 2024 | CNY 6.89M | 0.01 | - |
| 2023 | CNY 4.60M | 0.01 | - |
| 2022 | CNY 1.35M | 0.00 | - |
| 2021 | CNY 1.68M | 0.00 | - |
| 2020 | CNY 623K | 0.00 | - |
| 2019 | CNY 623K | 0.00 | 3.6% |
| 2018 | CNY 213.77 | 0.00 | - |
| 2017 | CNY 2.70M | 0.00 | 16.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 12:10 on Jun 10, 2011.
Who owns China Reform Health Management and Services Group Co Ltd
- Insiders 31.38%
- Institutions 0.39%
- Public & others 68.23%
- Shares outstanding 979M
- Free float 709M
China Reform Health Management and Services Group Co Ltd company profile
- Company name
- China Reform Health Management and Services Group Co Ltd
- Ticker
- 000503.SHE
- ISIN
- CNE000000255
- Exchange
- Shenzhen Stock Exchange
- Listed since
- Oct 5, 1991
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 1,244
- Fiscal year end
- December
- Address
- Buildings 2 and 3, Beijing, China, 100009
- Phone
- 86 10 5782 5333
- Website
- crhms.com
About China Reform Health Management and Services Group Co Ltd
China Reform Health Management and Services Group Co., Ltd. offers medical insurance management services in China. The company provides medical insurance fund management, medical quality and safety, drug and medical device supervision, and internet-based health protection services. It is also involved in the pharmaceutical and medical business. The company was formerly known as SeaRainbow Holding Corp. and changed its name to China Reform Health Management and Services Group Co., Ltd. in May 2018. China Reform Health Management and Services Group Co., Ltd. was founded in 1986 and is headquartered in Beijing, China.
China Reform Health Management and Services Group Co Ltd management
5- Mr. Hongquan YuanGM & Non-Independent Director · born 1982
- Ms. Wei ZhouDeputy General Manager & General Counsel · born 1984
- Mr. Yingjie LiuDeputy GM & Director · born 1972
- Mr. Xinxing LiuBoard Secretary · born 1984
- Mr. Zhenhua ZhangDeputy General Manager · born 1984